Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention of adverse effects caused by CD3 specific binding domains

Prevention of adverse effects caused by CD3 specific binding domains

US Patent 11633408 · Granted Apr 25, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of acute lymphoblastic leukemia2023
Dosage regimen for administering a CD19xCD3 bispecific antibody to patients at r2023
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by2021
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by2021
Anti-leukocyte adhesion for the mitigation of potential adverse events caused by2021
Risk-stratification of B-precursor acute lymphoblastic leukemia patients2021
Administration of a bispecific construct binding to CD33 and CD3 for use in a me2021
Means and methods for treating DLBCL2020
Means and methods for treating DLBCL2020
Means and methods for treating DLBCL2020
Dosage regimen for administering a CD19XCD3 bispecific antibody2020
Dosage regimen for administering a CD19XCD3 bispecific antibody2020